Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GSK2402968
DRUG
2 trials
Sponsors
GlaxoSmithKline
Conditions
Muscular Dystrophies
Phase 2
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
Completed
NCT01153932
GlaxoSmithKline
Muscular Dystrophies
Start: 2010-09-30
End: 2012-09-30
Updated: 2014-08-25
Phase 3
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Terminated
NCT01480245
GlaxoSmithKline
Muscular Dystrophies
Start: 2011-09-30
End: 2014-03-31
Updated: 2017-03-23
Related Papers
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.
2014-09-07
228 citations